{"id":332220,"date":"2026-10-29T14:00:56","date_gmt":"2026-10-29T08:30:56","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/"},"modified":"2026-10-29T14:00:56","modified_gmt":"2026-10-29T08:30:56","slug":"krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/","title":{"rendered":"Krebs Biochemicals &#038; Industries Q2 Results FY27: Net Loss Narrows 12.05% to Rs 5.40 Cr on Revenue of Rs 5.79 Cr"},"content":{"rendered":"<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Krebs Biochemicals &#038; Industries Q2 Results FY27 were declared on 29 October 2026 on a Standalone basis. Krebs Biochemicals &#038; Industries reported revenue of Rs 5.79 Cr, up 38.85% YoY, and net loss of Rs 5.40 Cr, narrower by 12.05% than the net loss of Rs 6.14 Cr a year earlier. The quarterly results also show Operating Profit of Rs -1.93 Cr, an improvement of 30.82% from Rs -2.79 Cr a year earlier. YoY growth across these lines is covered in the sections below.<\/p>\n<\/div>\n<p><a href=\"https:\/\/univest.in\/stocks\/krebsbio\/krebs-biochemicals-and-industries-ltd-share-price-today\">Krebs Biochemicals &#038; Industries Ltd<\/a> (KREBSBIO) Q2 Results FY27 announced on 29 October 2026, covering the company&#8217;s financial performance for the July to September quarter. The results date brings Krebs Biochemicals &#038; Industries Q2 Results FY27 on a Standalone basis, with revenue of Rs 5.79 Cr and net loss of Rs 5.40 Cr. Compared with the same quarter last year, revenue was up 38.85% and the net loss was Rs 5.40 Cr, narrower by 12.05% than the net loss of Rs 6.14 Cr a year earlier. These standalone results are the base for the analysis that follows.<\/p>\n<p>This results analysis of Krebs Biochemicals &#038; Industries Q2 Results covers the financial highlights, the business drivers, the outlook and the key risks. Univest readers can use the Univest Screener alongside it to track how Krebs Biochemicals &#038; Industries compares on other metrics. The Financial Highlights section opens the numbers.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=quarterly_results\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#Krebs_Biochemicals_Industries_Q2_Results_FY27_Financial_Highlights\" title=\"Krebs Biochemicals &#038; Industries Q2 Results FY27: Financial Highlights\">Krebs Biochemicals &#038; Industries Q2 Results FY27: Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#Key_Takeaways_from_Krebs_Biochemicals_Industries_Q2_Results_What_Stands_Out\" title=\"Key Takeaways from Krebs Biochemicals &#038; Industries Q2 Results: What Stands Out\">Key Takeaways from Krebs Biochemicals &#038; Industries Q2 Results: What Stands Out<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#Krebs_Biochemicals_Industries_Q2_Results_FY27_Performance_Analysis\" title=\"Krebs Biochemicals &#038; Industries Q2 Results FY27: Performance Analysis\">Krebs Biochemicals &#038; Industries Q2 Results FY27: Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#Key_Business_Factors_This_Quarter\" title=\"Key Business Factors This Quarter\">Key Business Factors This Quarter<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#FY27_Outlook_After_Krebs_Biochemicals_Industries_Q2_Results\" title=\"FY27 Outlook After Krebs Biochemicals &#038; Industries Q2 Results\">FY27 Outlook After Krebs Biochemicals &#038; Industries Q2 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#Key_Risks_to_Watch_After_Krebs_Biochemicals_Industries_Q2_Results_FY27\" title=\"Key Risks to Watch After Krebs Biochemicals &#038; Industries Q2 Results FY27\">Key Risks to Watch After Krebs Biochemicals &#038; Industries Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#Net_Loss\" title=\"Net Loss\">Net Loss<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#Return_on_Equity\" title=\"Return on Equity\">Return on Equity<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#Return_on_Capital_Employed\" title=\"Return on Capital Employed\">Return on Capital Employed<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#Frequently_Asked_Questions_on_Krebs_Biochemicals_Industries_Q2_Results_FY27\" title=\"Frequently Asked Questions on Krebs Biochemicals &#038; Industries Q2 Results FY27\">Frequently Asked Questions on Krebs Biochemicals &#038; Industries Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#What_are_Krebs_Biochemicals_Industries_Q2_Results_FY27\" title=\"What are Krebs Biochemicals &#038; Industries Q2 Results FY27?\">What are Krebs Biochemicals &#038; Industries Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#What_is_the_results_date_for_Krebs_Biochemicals_Industries_Q2_Results_FY27\" title=\"What is the results date for Krebs Biochemicals &#038; Industries Q2 Results FY27?\">What is the results date for Krebs Biochemicals &#038; Industries Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#What_revenue_was_reported_in_Krebs_Biochemicals_Industries_Q2_Results_FY27\" title=\"What revenue was reported in Krebs Biochemicals &#038; Industries Q2 Results FY27?\">What revenue was reported in Krebs Biochemicals &#038; Industries Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#What_net_profit_was_reported_in_Krebs_Biochemicals_Industries_Q2_Results_FY27\" title=\"What net profit was reported in Krebs Biochemicals &#038; Industries Q2 Results FY27?\">What net profit was reported in Krebs Biochemicals &#038; Industries Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#How_much_YoY_growth_did_revenue_show_in_Krebs_Biochemicals_Industries_Q2_Results_FY27\" title=\"How much YoY growth did revenue show in Krebs Biochemicals &#038; Industries Q2 Results FY27?\">How much YoY growth did revenue show in Krebs Biochemicals &#038; Industries Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#Did_net_profit_rise_or_fall_in_Krebs_Biochemicals_Industries_Q2_Results\" title=\"Did net profit rise or fall in Krebs Biochemicals &#038; Industries Q2 Results?\">Did net profit rise or fall in Krebs Biochemicals &#038; Industries Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#What_was_the_Operating_Profit_in_Krebs_Biochemicals_Industries_Q2_Results_FY27\" title=\"What was the Operating Profit in Krebs Biochemicals &#038; Industries Q2 Results FY27?\">What was the Operating Profit in Krebs Biochemicals &#038; Industries Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#Are_Krebs_Biochemicals_Industries_Q2_Results_consolidated_results_or_standalone_results\" title=\"Are Krebs Biochemicals &#038; Industries Q2 Results consolidated results or standalone results?\">Are Krebs Biochemicals &#038; Industries Q2 Results consolidated results or standalone results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#What_business_factors_shaped_Krebs_Biochemicals_Industries_Q2_Results_FY27\" title=\"What business factors shaped Krebs Biochemicals &#038; Industries Q2 Results FY27?\">What business factors shaped Krebs Biochemicals &#038; Industries Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#What_are_the_key_risks_after_Krebs_Biochemicals_Industries_Q2_Results_FY27\" title=\"What are the key risks after Krebs Biochemicals &#038; Industries Q2 Results FY27?\">What are the key risks after Krebs Biochemicals &#038; Industries Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#What_is_the_outlook_after_Krebs_Biochemicals_Industries_Q2_Results\" title=\"What is the outlook after Krebs Biochemicals &#038; Industries Q2 Results?\">What is the outlook after Krebs Biochemicals &#038; Industries Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/krebs-biochemicals-and-industries-q2-results-fy27-loss-5-crore\/#Where_can_I_find_the_complete_Krebs_Biochemicals_Industries_Q2_Results_FY27_data\" title=\"Where can I find the complete Krebs Biochemicals &#038; Industries Q2 Results FY27 data?\">Where can I find the complete Krebs Biochemicals &#038; Industries Q2 Results FY27 data?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Krebs_Biochemicals_Industries_Q2_Results_FY27_Financial_Highlights\"><\/span><strong>Krebs Biochemicals &#038; Industries Q2 Results FY27: Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q2 FY27 (Sep 26)<\/th>\n<th>Q2 FY26 (Sep 25)<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<tr>\n<td><strong>Revenue<\/strong><\/td>\n<td>Rs 5.79 Cr<\/td>\n<td>Rs 4.17 Cr<\/td>\n<td>+38.85% YoY<\/td>\n<\/tr>\n<tr>\n<td><strong>Operating Profit<\/strong><\/td>\n<td>Rs -1.93 Cr<\/td>\n<td>Rs -2.79 Cr<\/td>\n<td>+30.82% YoY<\/td>\n<\/tr>\n<tr>\n<td><strong>Net Profit (PAT)<\/strong><\/td>\n<td>Rs -5.4 Cr<\/td>\n<td>Rs -6.14 Cr<\/td>\n<td>+12.05% YoY<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Source: company filing for Krebs Biochemicals &amp; Industries Q2 Results FY27, 29 October 2026. Figures in Rs Crore, Standalone basis.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Takeaways_from_Krebs_Biochemicals_Industries_Q2_Results_What_Stands_Out\"><\/span><strong>Key Takeaways from Krebs Biochemicals &#038; Industries Q2 Results: What Stands Out<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Revenue:<\/strong> Krebs Biochemicals &#038; Industries reported revenue of Rs 5.79 Cr, up 38.85% YoY against Rs 4.17 Cr in the same quarter of the previous year.<\/li>\n<li><strong>Net loss:<\/strong> Net loss stood at Rs 5.40 Cr, narrower by 12.05% than the net loss of Rs 6.14 Cr a year earlier, which sets the YoY growth picture for the bottom line.<\/li>\n<li><strong>Operating Profit:<\/strong> Operating Profit came in at Rs -1.93 Cr, an improvement of 30.82% from Rs -2.79 Cr a year earlier, which adds a third line to the YoY growth comparison.<\/li>\n<li><strong>Basis:<\/strong> Krebs Biochemicals &#038; Industries Q2 Results FY27 are standalone results declared on 29 October 2026, so every figure in this article follows that single reporting basis.<\/li>\n<li><strong>Margin:<\/strong> Net profit margin improved to -93.3% from -147.2% in the comparison quarter. This links the revenue and net profit lines in the same quarter.<\/li>\n<li><strong>Next:<\/strong> The performance analysis below sets out how revenue and profit moved against the same quarter last year.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Krebs_Biochemicals_Industries_Q2_Results_FY27_Performance_Analysis\"><\/span><strong>Krebs Biochemicals &#038; Industries Q2 Results FY27: Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Krebs Biochemicals &#038; Industries Q2 Results FY27 show that Krebs Biochemicals &#038; Industries reported revenue of Rs 5.79 Cr, up 38.85% YoY, and net loss of Rs 5.40 Cr, narrower by 12.05% than the net loss of Rs 6.14 Cr a year earlier. Operating Profit was Rs -1.93 Cr, an improvement of 30.82% from Rs -2.79 Cr a year earlier. These are the headline standalone results for the quarter.<\/p>\n<p>The same quarter last year recorded revenue of Rs 4.17 Cr and a net loss of Rs 6.14 Cr, which is the base for every YoY growth figure here. In Krebs Biochemicals &#038; Industries Q2 Results, the revenue change of 38.85% and the net profit change, a net loss that is 12.05% narrower than the Rs 6.14 Cr net loss a year earlier, move at different rates, so the two lines are best read together.<\/p>\n<p>The quarterly results therefore give two readings: a top-line change of 38.85% and a bottom-line net loss of Rs 5.40 Cr. Krebs Biochemicals &#038; Industries Q2 Results FY27 also leave the next question open, namely what drove these numbers, which is where the results analysis turns to the business factors.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live results data<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_This_Quarter\"><\/span><strong>Key Business Factors This Quarter<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Revenue Trend<\/strong> &#8211; The results analysis points to this first business factor. Revenue grew 38.8% year on year to Rs 5.79 Cr in the latest quarter. Revenue is the first line of the statement, so this movement sets the base for every profit figure that follows in the results.<\/p>\n<p><strong>Net Profit Margin<\/strong> &#8211; Net profit margin improved to -93.3% from -147.2% in the comparison quarter. Margin shows how much of each rupee of revenue reached net profit, which links the revenue figure to the bottom line in the same quarter. Krebs Biochemicals &#038; Industries Q2 Results FY27 carry this into the standalone results reported on 29 October 2026.<\/p>\n<p><strong>Debt Level<\/strong> &#8211; Company is almost debt free, with a debt-to-assets ratio of -1.38 in FY26. This balance-sheet reference sits alongside the quarterly figures and frames how the reported profit relates to the company&#8217;s borrowings. The quarterly results place it next to the headline revenue and net profit figures.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FY27_Outlook_After_Krebs_Biochemicals_Industries_Q2_Results\"><\/span><strong>FY27 Outlook After Krebs Biochemicals &#038; Industries Q2 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The FY27 view starts from what the quarter shows for Krebs Biochemicals &#038; Industries. Krebs Biochemicals &#038; Industries has reported revenue of Rs 5.79 Cr and net loss of Rs 5.40 Cr for Q2, and full-year FY27 results will depend on the quarters still to be declared.<\/p>\n<p>The results analysis for FY27 therefore rests on subsequent quarterly disclosures and on disclosed sector conditions, not on any projection. The net loss of Rs 5.40 Cr is one data point in that series, and readers can follow later filings on Univest. That makes it important to review the risks recorded for this quarter.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Watch_After_Krebs_Biochemicals_Industries_Q2_Results_FY27\"><\/span><strong>Key Risks to Watch After Krebs Biochemicals &#038; Industries Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Net_Loss\"><\/span><strong>Net Loss<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Company reported a net loss of Rs 5.40 Cr in the latest quarter. A loss in the latest quarter makes the direction of the next disclosure the key item to follow. This sits next to the YoY growth of 38.85% in revenue reported in Krebs Biochemicals &#038; Industries Q2 Results FY27.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Return_on_Equity\"><\/span><strong>Return on Equity<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Return on equity was low at 0.00% in FY26. A weak ratio indicates how little annual profit is generated per rupee of shareholder equity and is a reference for the quality of earnings.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Return_on_Capital_Employed\"><\/span><strong>Return on Capital Employed<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Return on capital employed was modest at -15.38% in FY26. A modest ratio indicates how much operating earnings the business generates on the capital employed in it over a full year. The next disclosure will show whether this level continues.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track quarterly results as they are declared.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Krebs Biochemicals &#038; Industries Q2 Results FY27 show revenue of Rs 5.79 Cr and net loss of Rs 5.40 Cr on a Standalone basis, declared on 29 October 2026. These quarterly results should be read together with the risks above and the reference ratios listed. For a quick summary of Krebs Biochemicals &#038; Industries Q2 Results, these standalone results are the figures to note. Investors should consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Krebs_Biochemicals_Industries_Q2_Results_FY27\"><\/span><strong>Frequently Asked Questions on Krebs Biochemicals &#038; Industries Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_are_Krebs_Biochemicals_Industries_Q2_Results_FY27\"><\/span><strong>What are Krebs Biochemicals &#038; Industries Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Krebs Biochemicals &#038; Industries Q2 Results FY27 report revenue of Rs 5.79 Cr and net loss of Rs 5.40 Cr for July to September 2026. Alongside this, the Quick Answer summarises both figures.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_results_date_for_Krebs_Biochemicals_Industries_Q2_Results_FY27\"><\/span><strong>What is the results date for Krebs Biochemicals &#038; Industries Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Krebs Biochemicals &#038; Industries declared its quarterly results on 29 October 2026 for the July to September 2026 quarter. This results date applies to the standalone results covered in the introduction of this article.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_revenue_was_reported_in_Krebs_Biochemicals_Industries_Q2_Results_FY27\"><\/span><strong>What revenue was reported in Krebs Biochemicals &#038; Industries Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Krebs Biochemicals &#038; Industries reported revenue of Rs 5.79 Cr, compared with Rs 4.17 Cr a year earlier, so the Financial Highlights table shows the YoY change as up 38.85%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_net_profit_was_reported_in_Krebs_Biochemicals_Industries_Q2_Results_FY27\"><\/span><strong>What net profit was reported in Krebs Biochemicals &#038; Industries Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Krebs Biochemicals &#038; Industries reported a net loss of Rs 5.40 Cr, narrower by 12.05% than the net loss of Rs 6.14 Cr a year earlier, while the Performance Analysis section explains how this compares with revenue.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_YoY_growth_did_revenue_show_in_Krebs_Biochemicals_Industries_Q2_Results_FY27\"><\/span><strong>How much YoY growth did revenue show in Krebs Biochemicals &#038; Industries Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue moved up 38.85% YoY to Rs 5.79 Cr, which means the top line grew against Rs 4.17 Cr; the Key Takeaways section lists this first for the quarter.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_net_profit_rise_or_fall_in_Krebs_Biochemicals_Industries_Q2_Results\"><\/span><strong>Did net profit rise or fall in Krebs Biochemicals &#038; Industries Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The net loss was Rs 5.40 Cr against Rs 6.14 Cr a year earlier, so the YoY direction is a narrower loss; the Performance Analysis section sets this against revenue.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_Operating_Profit_in_Krebs_Biochemicals_Industries_Q2_Results_FY27\"><\/span><strong>What was the Operating Profit in Krebs Biochemicals &#038; Industries Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Krebs Biochemicals &#038; Industries Q2 Results FY27 show Operating Profit of Rs -1.93 Cr, an improvement of 30.82% from Rs -2.79 Cr a year earlier. Alongside this, the Performance Analysis section sets it against revenue of Rs 5.79 Cr.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Are_Krebs_Biochemicals_Industries_Q2_Results_consolidated_results_or_standalone_results\"><\/span><strong>Are Krebs Biochemicals &#038; Industries Q2 Results consolidated results or standalone results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Krebs Biochemicals &#038; Industries Q2 Results are standalone results reported by Krebs Biochemicals &#038; Industries on 29 October 2026, so every figure follows that basis, as the Quick Answer and Conclusion state.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_business_factors_shaped_Krebs_Biochemicals_Industries_Q2_Results_FY27\"><\/span><strong>What business factors shaped Krebs Biochemicals &#038; Industries Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The business factors include: Revenue grew 38.8% year on year to Rs 5.79 Cr in the latest quarter. Alongside this, the Key Business Factors section lists the others.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_after_Krebs_Biochemicals_Industries_Q2_Results_FY27\"><\/span><strong>What are the key risks after Krebs Biochemicals &#038; Industries Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The risks include: Company reported a net loss of Rs 5.40 Cr in the latest quarter. Alongside this, the Key Risks to Watch section covers the others.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_outlook_after_Krebs_Biochemicals_Industries_Q2_Results\"><\/span><strong>What is the outlook after Krebs Biochemicals &#038; Industries Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The FY27 view rests on later quarterly disclosures and disclosed sector conditions, which means the FY27 Outlook section stays tied to the Q2 numbers reported so far for Krebs Biochemicals &#038; Industries.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_find_the_complete_Krebs_Biochemicals_Industries_Q2_Results_FY27_data\"><\/span><strong>Where can I find the complete Krebs Biochemicals &#038; Industries Q2 Results FY27 data?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Financial Highlights table in this article lists revenue and net profit for the quarter and the same quarter last year, and the Univest Screener tracks Krebs Biochemicals &#038; Industries alongside other companies.<\/p>\n<p><script type=\"application\/ld+json\" class=\"faq-schema\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are Krebs Biochemicals & Industries Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Krebs Biochemicals & Industries Q2 Results FY27 report revenue of Rs 5.79 Cr and net loss of Rs 5.40 Cr for July to September 2026. Alongside this, the Quick Answer summarises both figures.\"}},{\"@type\":\"Question\",\"name\":\"What is the results date for Krebs Biochemicals & Industries Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Krebs Biochemicals & Industries declared its quarterly results on 29 October 2026 for the July to September 2026 quarter. This results date applies to the standalone results covered in the introduction of this article.\"}},{\"@type\":\"Question\",\"name\":\"What revenue was reported in Krebs Biochemicals & Industries Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Krebs Biochemicals & Industries reported revenue of Rs 5.79 Cr, compared with Rs 4.17 Cr a year earlier, so the Financial Highlights table shows the YoY change as up 38.85%.\"}},{\"@type\":\"Question\",\"name\":\"What net profit was reported in Krebs Biochemicals & Industries Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Krebs Biochemicals & Industries reported a net loss of Rs 5.40 Cr, narrower by 12.05% than the net loss of Rs 6.14 Cr a year earlier, while the Performance Analysis section explains how this compares with revenue.\"}},{\"@type\":\"Question\",\"name\":\"How much YoY growth did revenue show in Krebs Biochemicals & Industries Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue moved up 38.85% YoY to Rs 5.79 Cr, which means the top line grew against Rs 4.17 Cr; the Key Takeaways section lists this first for the quarter.\"}},{\"@type\":\"Question\",\"name\":\"Did net profit rise or fall in Krebs Biochemicals & Industries Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The net loss was Rs 5.40 Cr against Rs 6.14 Cr a year earlier, so the YoY direction is a narrower loss; the Performance Analysis section sets this against revenue.\"}},{\"@type\":\"Question\",\"name\":\"What was the Operating Profit in Krebs Biochemicals & Industries Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Krebs Biochemicals & Industries Q2 Results FY27 show Operating Profit of Rs -1.93 Cr, an improvement of 30.82% from Rs -2.79 Cr a year earlier. Alongside this, the Performance Analysis section sets it against revenue of Rs 5.79 Cr.\"}},{\"@type\":\"Question\",\"name\":\"Are Krebs Biochemicals & Industries Q2 Results consolidated results or standalone results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Krebs Biochemicals & Industries Q2 Results are standalone results reported by Krebs Biochemicals & Industries on 29 October 2026, so every figure follows that basis, as the Quick Answer and Conclusion state.\"}},{\"@type\":\"Question\",\"name\":\"What business factors shaped Krebs Biochemicals & Industries Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The business factors include: Revenue grew 38.8% year on year to Rs 5.79 Cr in the latest quarter. Alongside this, the Key Business Factors section lists the others.\"}},{\"@type\":\"Question\",\"name\":\"What are the key risks after Krebs Biochemicals & Industries Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The risks include: Company reported a net loss of Rs 5.40 Cr in the latest quarter. Alongside this, the Key Risks to Watch section covers the others.\"}},{\"@type\":\"Question\",\"name\":\"What is the outlook after Krebs Biochemicals & Industries Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The FY27 view rests on later quarterly disclosures and disclosed sector conditions, which means the FY27 Outlook section stays tied to the Q2 numbers reported so far for Krebs Biochemicals & Industries.\"}},{\"@type\":\"Question\",\"name\":\"Where can I find the complete Krebs Biochemicals & Industries Q2 Results FY27 data?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Financial Highlights table in this article lists revenue and net profit for the quarter and the same quarter last year, and the Univest Screener tracks Krebs Biochemicals & Industries alongside other companies.\"}}]}<\/script><br \/>\n<script type=\"application\/ld+json\" class=\"news-article-schema\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"Krebs Biochemicals & Industries Q2 Results FY27: Net Loss Narrows 12.05% to Rs 5.40 Cr on Revenue of Rs 5.79 C\",\"description\":\"Krebs Biochemicals & Industries Q2 Results: Standalone revenue \u20b95.79 Cr, net loss \u20b95.40 Cr. See YoY growth and net profit from the 29 October 2026 filing.\",\"author\":{\"@type\":\"Organization\",\"name\":\"Univest\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Univest\",\"url\":\"https:\/\/univest.in\"},\"about\":{\"@type\":\"Corporation\",\"name\":\"Krebs Biochemicals & Industries Ltd\"}}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Krebs Biochemicals &#038; Industries Q2 Results FY27: revenue Rs 5.79 Cr, net profit Rs 5.40 Cr on a standalone basis.<\/p>\n","protected":false},"author":29,"featured_media":332216,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5331],"tags":[],"class_list":["post-332220","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-https-univest-in-blogs-category-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["332216"],"rank_math_title":["Krebs Biochemicals &amp; Industries Q2 Results FY27: Net Loss Narrows 12.05% to Rs 5.40 Cr"],"rank_math_description":["Krebs Biochemicals &amp; Industries Q2 Results: Standalone revenue \u20b95.79 Cr, net loss \u20b95.40 Cr. See YoY growth and net profit from the 29 October 2026 filing."],"rank_math_focus_keyword":["Krebs Biochemicals & Industries Q2 Results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/krebs-biochemicals-and-industries-q2-results-fy27-net-loss-narrows-12-05-to-rs-5.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/332220","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=332220"}],"version-history":[{"count":0,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/332220\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/332216"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=332220"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=332220"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=332220"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}